Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
CC Yao, JH Wang, CH Chen, CH Hung, YH Yen… - Diagnostics, 2023 - mdpi.com
Background: The role of des-γ-carboxy prothrombin (DCP) in patients undergoing
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified …
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified …
High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma
M Kobayashi, K Ikeda, Y Kawamura, H Yatsuji… - Cancer, 2009 - Wiley Online Library
BACKGROUND: Currently, surgical resection is considered the first‐line treatment for early
stage hepatocellular carcinoma (HCC). Radiofrequency ablation (RFA) has been an …
stage hepatocellular carcinoma (HCC). Radiofrequency ablation (RFA) has been an …
Post‐ablation des‐gamma‐carboxy prothrombin level predicts prognosis in hepatitis B‐related hepatocellular carcinoma
Abstract Background & Aims We investigated whether pre‐or post‐ablation serum alpha‐
foetoprotein (AFP) and des‐gamma‐carboxy prothrombin (DCP) levels can predict …
foetoprotein (AFP) and des‐gamma‐carboxy prothrombin (DCP) levels can predict …
Clinical utility of des-γ-carboxy prothrombin kinetics as a complement to radiologic response in patients with hepatocellular carcinoma undergoing transarterial …
WH Park, JH Shim, SB Han, HJ Won, YM Shin… - Journal of Vascular and …, 2012 - Elsevier
PURPOSE: Serial α-fetoprotein (AFP) measurements are useful for assessing tumor
responses to numerous therapies for hepatocellular carcinoma (HCC). This study tested the …
responses to numerous therapies for hepatocellular carcinoma (HCC). This study tested the …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLoS One, 2019 - journals.plos.org
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy
S Takahashi, M Kudo, H Chung, T Inoue, E Ishikawa… - Oncology, 2008 - karger.com
Objective: This study was undertaken to assess the prognostic predictor in patients with
hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA). Methods: This study …
hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA). Methods: This study …
Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation
T Beppu, K Sugimoto, K Shiraki… - International …, 2010 - spandidos-publications.com
The aim of this study was to elucidate the importance of three tumor markers, α-fetoprotein
(AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-γ-carboxy …
(AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-γ-carboxy …
Rapid and early α‑fetoprotein and des‑γ‑carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced …
K Oyama, M Koda, T Sugihara… - Molecular and …, 2015 - spandidos-publications.com
The aim of the present study was to predict the effects of transarterial infusion (TAI)
chemotherapy based on early changes in α‑fetoprotein (AFP) and des‑γ‑carboxy …
chemotherapy based on early changes in α‑fetoprotein (AFP) and des‑γ‑carboxy …
Early on‐treatment predictions of clinical outcomes using alpha‐fetoprotein and des‐gamma‐carboxy prothrombin responses in patients with advanced hepatocellular …
Abstract Background and Aim: The clinical utility of alpha‐fetoprotein (AFP) and des‐γ‐
carboxy prothrombin (DCP) as a predictor of treatment outcome in patients with advanced …
carboxy prothrombin (DCP) as a predictor of treatment outcome in patients with advanced …
The half-life of serum des-gamma-carboxy prothrombin is a prognostic index of survival and recurrence after liver resection for hepatocellular carcinoma
Y Okamura, T Sugiura, T Ito, Y Yamamoto… - Annals of surgical …, 2016 - Springer
Background Des-γ-carboxy prothrombin (DCP) is a representative tumor marker of
hepatocellular carcinoma (HCC), and its values are occasionally very high in HCC cases …
hepatocellular carcinoma (HCC), and its values are occasionally very high in HCC cases …
相关搜索
- γ carboxy hepatocellular carcinoma
- radiofrequency ablation hepatocellular carcinoma
- γ carboxy radiofrequency ablation
- γ carboxy early prediction
- radiofrequency ablation early prediction
- hepatocellular carcinoma early prediction
- γ carboxy prothrombin responses
- γ carboxy treatment outcomes
- hepatocellular carcinoma half life
- gamma carboxy half life
- hepatocellular carcinoma radiologic response
- hepatocellular carcinoma survival and recurrence
- treatment outcomes prothrombin responses
- γ carboxy prognostic value
- hepatocellular carcinoma prognostic value
- γ carboxy meta analysis